Shengtao Yuan

Prof. Dr. Shengtao Yuan


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
LZLiufeng Zhang
Liufeng Zhang
YWYuancheng Wei
Yuancheng Wei
SYShengtao Yuan
Shengtao Yuan
LSLi Sun
Li Sun
Abnormal energy metabolism is a characteristic of tumor cells, and mitochondria are important components of tumor metabolic reprogramming. Mitochondria have gradually received the attention of scientists due to their important functions, such as providing chemical energy, producing substrates for tumor anabolism, controlling REDOX and calcium homeostasis, participating in the regulation of transcription, and controlling cell death. Based on the concept of reprogramming mitochondrial metabolism, a range of drugs have been developed to target the mitochondria. In this review, we discuss the current progress in mitochondrial metabolic reprogramming and summarized the corresponding treatment options. Finally, we propose mitochondrial inner membrane transporters as new and feasible therapeutic targets.

20 October 2023 in Cancers
Verified
Journal Article
Open access
PDF file
XLXiao-Dan Lyu
Xiao-Dan Lyu
YLYang Liu
Yang Liu
JWJia Wang
Jia Wang
YWYuan-Cheng Wei
Yuan-Cheng Wei
YHYi Han
Yi Han
LSLi Sun
Li Sun
Background: The microtubule protein inhibitor C118P shows excellent anti-breast cancer effects. However, the potential targets and mechanisms of C118P in breast cancer remain unknown. Methods: Real-time cellular analysis (RTCA) was used to detect cell viability. Apoptosis and the cell cycle were detected by flow cytometry. Computer docking simulations, surface plasmon resonance (SPR) technology, and microscale thermophoresis (MST) were conducted to study the interaction between C118P and alanine-serine-cysteine transporter 2 (ASCT2). Seahorse XF technology was used to measure the basal oxygen consumption rate (OCR). The effect of C118P in the adipose microenvironment was explored using a co-culture model of adipocytes and breast cancer cells and mouse cytokine chip. Results: C118P inhibited proliferation, potentiated apoptosis, and induced G2/M cell cycle arrest in breast cancer cells. Notably, ASCT2 was validated as a C118P target through reverse docking, SPR, and MST. C118P suppressed glutamine metabolism and mediated autophagy via ASCT2. Similar results were obtained in the adipocyte–breast cancer microenvironment. Adipose-derived interleukin-6 (IL-6) promoted the proliferation of breast cancer cells by enhancing glutamine metabolism via ASCT2. C118P inhibited the upregulation of ASCT2 by inhibiting the effect of IL-6 in co-cultures. Conclusion: C118P exerts an antitumour effect against breast cancer via the glutamine transporter ASCT2.

1 September 2023 in Oncogene
Verified
Journal Article
Closed access
PDF file
DDDanyu Du
Danyu Du
MQMengyao Qin
Mengyao Qin
LSLi Shi
Li Shi
CLChan Liu
Chan Liu
JJJingwei Jiang
Jingwei Jiang
JXJing Xiong
Jing Xiong

17 June 2023 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
DDDanyu Du
Danyu Du
SWShuai Wang
Shuai Wang
TLTao Li
Tao Li
ZLZhengrui Liu
Zhengrui Liu
MYMei Yang
Mei Yang
SYShengtao Yuan
Shengtao Yuan

4 February 2025 in European Journal of Pharmacology
Verified
Journal Article
Closed access
YWYuancheng Wei
Yuancheng Wei
XLXiaodan Lyu
Xiaodan Lyu
JWJia Wang
Jia Wang
LZLiufeng Zhang
Liufeng Zhang
CXChenxi Xu
Chenxi Xu
LSLi Sun
Li Sun

6 November 2023 in European Journal of Pharmacology
Verified
Journal Article
Closed access
YXYannan Xia
Yannan Xia
SZShujie Zhang
Shujie Zhang
HLHongyi Luo
Hongyi Luo
YWYumeng Wang
Yumeng Wang
YJYuanyuan Jiang
Yuanyuan Jiang
SYShengtao Yuan
Shengtao Yuan